US Edition
Uncertain Future for Trump's Most Favored Nation Model to Lower Drug Prices
Summary by healtheconomics.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Uncertain Future for Trump's Most Favored Nation Model to Lower Drug Prices
Since Donald Trump’s executive order in May, which promised to reduce U.S. prescription drug prices by 30% to 80%, the administration has not released any specifics on implementing the “most favored nation” model. This model aims to tie U.S. drug prices to those in comparably wealthy nations, yet pharmaceutical executives have noted a lack of clarity from the administration. The only publicly known detail is that prices would be benchmarked agai…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
